<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Pharma News from PharmiWeb.com</title><link>http://www.pharmiweb.com/</link><description>Global news and press releases from the Pharmaceutical industry</description><language>en-gb</language><image><link>http://www.Pharmiweb.com</link><url>http://www.pharmiweb.com/images/logos/pweb_logo.gif</url><title>PharmiWeb.com</title></image><copyright>&amp;#169; 1998 - 2009 PharmiWeb Solutions - All Rights Reserved</copyright><lastBuildDate>Wed, 15 Jul 2009 18:00:00 PDT</lastBuildDate><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/Pharmaceutical-News" type="application/rss+xml" /><feedburner:emailServiceId>Pharmaceutical-News</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item><title>INSTITUTE OF CLINICAL RESEARCH CARRIES OUT TRAINING FOR SAUDI ARABIA GOVERNMEN</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/JC3JKYd_uN4/pressrel.asp</link><pubDate>Wed, 15 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;INSTITUTE OF CLINICAL RESEARCH CARRIES OUT TRAINING FOR SAUDI ARABIA GOVERNMEN&lt;/strong&gt;&lt;br /&gt;The Institute of Clinical Research (ICR) has open...&lt;br /&gt;ICR, Institute of clinical research&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=JC3JKYd_uN4:QJWgqAyQ9bA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=JC3JKYd_uN4:QJWgqAyQ9bA:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=JC3JKYd_uN4:QJWgqAyQ9bA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=JC3JKYd_uN4:QJWgqAyQ9bA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/JC3JKYd_uN4" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7224</feedburner:origLink></item><item><title>CORNISH REGULATORY AFFAIRS COMPANY SUPPORTS LOCAL CHARITY</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/0szAk1PlpnY/pressrel.asp</link><pubDate>Wed, 15 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;CORNISH REGULATORY AFFAIRS COMPANY SUPPORTS LOCAL CHARITY&lt;/strong&gt;&lt;br /&gt;Regulatory Affairs specialist TRAC is playing a major role in helping ...&lt;br /&gt;TRAC&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=0szAk1PlpnY:7YmSRwCnljU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=0szAk1PlpnY:7YmSRwCnljU:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=0szAk1PlpnY:7YmSRwCnljU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=0szAk1PlpnY:7YmSRwCnljU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/0szAk1PlpnY" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7223</feedburner:origLink></item><item><title>CSL Backs Key Training Program for Health and Medical Sciences</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/IEVHBaOKe8o/pressrel.asp</link><pubDate>Wed, 15 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;CSL Backs Key Training Program for Health and Medical Sciences&lt;/strong&gt;&lt;br /&gt;The Bio21 Cluster today announced sponsorship of its flagship edu...&lt;br /&gt;CSL&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=IEVHBaOKe8o:Rq5PxwFwIeo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=IEVHBaOKe8o:Rq5PxwFwIeo:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=IEVHBaOKe8o:Rq5PxwFwIeo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=IEVHBaOKe8o:Rq5PxwFwIeo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/IEVHBaOKe8o" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7220</feedburner:origLink></item><item><title>Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/G_a23O2kyf0/pressrel.asp</link><pubDate>Wed, 15 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)&lt;/strong&gt;&lt;br /&gt;MORRISTOWN, N.J., July 15 /PRNewswire-Firs...&lt;br /&gt;Watson Pharmaceuticals, Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=G_a23O2kyf0:QweDY6ORf9I:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=G_a23O2kyf0:QweDY6ORf9I:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=G_a23O2kyf0:QweDY6ORf9I:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=G_a23O2kyf0:QweDY6ORf9I:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/G_a23O2kyf0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7219</feedburner:origLink></item><item><title>Wyeth Announces Results of the Company's Offer Relating to Holder Right to Surrender Convertible Debentures</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/_tM5TsBDLVo/pressrel.asp</link><pubDate>Wed, 15 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Wyeth Announces Results of the Company&amp;apos;s Offer Relating to Holder Right to Surrender Convertible Debentures&lt;/strong&gt;&lt;br /&gt;Madison, N.J., ...&lt;br /&gt;Wyeth&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_tM5TsBDLVo:HYKYI9bcveU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_tM5TsBDLVo:HYKYI9bcveU:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_tM5TsBDLVo:HYKYI9bcveU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=_tM5TsBDLVo:HYKYI9bcveU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/_tM5TsBDLVo" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7218</feedburner:origLink></item><item><title>GONAL-f Approved in Japan for Ovulation Induction in Infertile Women</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/_pnguAP6PE4/pressrel.asp</link><pubDate>Wed, 15 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;GONAL-f Approved in Japan for Ovulation Induction in Infertile Women&lt;/strong&gt;&lt;br /&gt;Geneva, Switzerland, July 16, 2009 &amp;amp;ndash; Merck Serono...&lt;br /&gt;Merck Serono&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_pnguAP6PE4:yJtP7FAAR7w:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_pnguAP6PE4:yJtP7FAAR7w:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_pnguAP6PE4:yJtP7FAAR7w:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=_pnguAP6PE4:yJtP7FAAR7w:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/_pnguAP6PE4" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7217</feedburner:origLink></item><item><title>Chief Medical Officer ‘Very Concerned’ about Obama’s Healthcare Reform Agenda</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/8AsDAPlJWbs/pressrel.asp</link><pubDate>Wed, 15 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Chief Medical Officer ‘Very Concerned’ about Obama’s Healthcare Reform Agenda&lt;/strong&gt;&lt;br /&gt;Robert Spiegel, Senior Vice President and Chief Me...&lt;br /&gt;Schering-Plough Corporation&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=8AsDAPlJWbs:DCQrvDx-xsA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=8AsDAPlJWbs:DCQrvDx-xsA:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=8AsDAPlJWbs:DCQrvDx-xsA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=8AsDAPlJWbs:DCQrvDx-xsA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/8AsDAPlJWbs" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7215</feedburner:origLink></item><item><title>DEVELOPMENTS IN WOUND MANAGEMENT TO REVOLUTIONISE TRADITIONAL PRACTICES</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/_aj7iN5QBFc/pressrel.asp</link><pubDate>Tue, 14 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;DEVELOPMENTS IN WOUND MANAGEMENT TO REVOLUTIONISE TRADITIONAL PRACTICES&lt;/strong&gt;&lt;br /&gt;Infection of surgical wounds is a significant clinical p...&lt;br /&gt;Royal Pharmaceutical Society of Great Britain&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_aj7iN5QBFc:3Ftv6kyx7gc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_aj7iN5QBFc:3Ftv6kyx7gc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_aj7iN5QBFc:3Ftv6kyx7gc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=_aj7iN5QBFc:3Ftv6kyx7gc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/_aj7iN5QBFc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7210</feedburner:origLink></item><item><title>AXURA®/AKATINOL® (Memantine) enhances communication abilities in patients with Alzheimer´s disease – for a longer integration in social and family life</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/cA9gQm9tC-o/pressrel.asp</link><pubDate>Tue, 14 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;AXURA®/AKATINOL® (Memantine) enhances communication abilities in patients with Alzheimer´s disease – for a longer integration in social and fa...&lt;br /&gt;Merz Pharmaceuticals&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=cA9gQm9tC-o:zf_ETNEhsL4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=cA9gQm9tC-o:zf_ETNEhsL4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=cA9gQm9tC-o:zf_ETNEhsL4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=cA9gQm9tC-o:zf_ETNEhsL4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/cA9gQm9tC-o" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7208</feedburner:origLink></item><item><title>Wyeth Consumer Healthcare Announces the Availability of New Centrum Ultra Line of Multivitamins Specially Formulated for Women and Men</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/bSkBGfyt2eg/pressrel.asp</link><pubDate>Tue, 14 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Wyeth Consumer Healthcare Announces the Availability of New Centrum Ultra Line of Multivitamins Specially Formulated for Women and Men&lt;/strong...&lt;br /&gt;Wyeth Consumer Healthcare&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=bSkBGfyt2eg:b3VH58UuC6M:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=bSkBGfyt2eg:b3VH58UuC6M:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=bSkBGfyt2eg:b3VH58UuC6M:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=bSkBGfyt2eg:b3VH58UuC6M:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/bSkBGfyt2eg" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7207</feedburner:origLink></item><item><title>GSK announces new commitments to fight HIV/AIDS in Sub-Saharan Africa - special focus on care and treatment of children</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/EgsjKz73CCo/pressrel.asp</link><pubDate>Tue, 14 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;GSK announces new commitments to fight HIV/AIDS in Sub-Saharan Africa - special focus on care and treatment of children&lt;/strong&gt;&lt;br /&gt;- New &amp;a...&lt;br /&gt;GlaxoSmithKline&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=EgsjKz73CCo:0qnLkKjxANQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=EgsjKz73CCo:0qnLkKjxANQ:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=EgsjKz73CCo:0qnLkKjxANQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=EgsjKz73CCo:0qnLkKjxANQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/EgsjKz73CCo" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7206</feedburner:origLink></item><item><title>Aegate Reaches Two Million Authentication Landmark</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/rnGI4Eq7MEc/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Aegate Reaches Two Million Authentication Landmark&lt;/strong&gt;&lt;br /&gt;Europe&amp;amp;rsquo;s only fully operational drug authentication service has mor...&lt;br /&gt;Aegate&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=rnGI4Eq7MEc:hHwZ5OhymMc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=rnGI4Eq7MEc:hHwZ5OhymMc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=rnGI4Eq7MEc:hHwZ5OhymMc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=rnGI4Eq7MEc:hHwZ5OhymMc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/rnGI4Eq7MEc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7203</feedburner:origLink></item><item><title>NEW CHAIR TO SPEARHEAD ERBI’S NEW PHASE</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/_G8SIxWSHc8/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;NEW CHAIR TO SPEARHEAD ERBI’S NEW PHASE&lt;/strong&gt;&lt;br /&gt;Developing Europe&amp;amp;rsquo;s largest lifescience and healthcare cluster 

ERBI is del...&lt;br /&gt;ERBI&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_G8SIxWSHc8:BNA_sO_xfWI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_G8SIxWSHc8:BNA_sO_xfWI:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=_G8SIxWSHc8:BNA_sO_xfWI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=_G8SIxWSHc8:BNA_sO_xfWI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/_G8SIxWSHc8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7202</feedburner:origLink></item><item><title>Study Evaluating Efficacy and Safety of Two Low-dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Published</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/TcpbHnz4o8g/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Study Evaluating Efficacy and Safety of Two Low-dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atroph...&lt;br /&gt;Wyeth Pharmaceuticals&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=TcpbHnz4o8g:G_523M4AlbM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=TcpbHnz4o8g:G_523M4AlbM:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=TcpbHnz4o8g:G_523M4AlbM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=TcpbHnz4o8g:G_523M4AlbM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/TcpbHnz4o8g" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7200</feedburner:origLink></item><item><title>New data from phase III SATURN study shows Tarceva improves overall survival when used immediately after initial chemotherapy in patients with advanced lung cancer</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/adxtrJD_qcw/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;New data from phase III SATURN study shows Tarceva improves overall survival when used immediately after initial chemotherapy in patients with...&lt;br /&gt;Roche&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=adxtrJD_qcw:vIBsF9fWBlk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=adxtrJD_qcw:vIBsF9fWBlk:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=adxtrJD_qcw:vIBsF9fWBlk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=adxtrJD_qcw:vIBsF9fWBlk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/adxtrJD_qcw" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7199</feedburner:origLink></item><item><title>Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/N1PIxeWC5Zc/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy&lt;/strong&gt;&lt;br /&gt;DES PLAI...&lt;br /&gt;Abbott&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=N1PIxeWC5Zc:QBy_DYjiJnc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=N1PIxeWC5Zc:QBy_DYjiJnc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=N1PIxeWC5Zc:QBy_DYjiJnc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=N1PIxeWC5Zc:QBy_DYjiJnc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/N1PIxeWC5Zc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7198</feedburner:origLink></item><item><title>Monitoring Circulating Tumor Cells with the Cellsearch® System Can Predict Prognosis in Metastatic Breast Cancer</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/9PpPtkGOlVs/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Monitoring Circulating Tumor Cells with the Cellsearch® System Can Predict Prognosis in Metastatic Breast Cancer&lt;/strong&gt;&lt;br /&gt;New Study Reinf...&lt;br /&gt;Johnson &amp;amp; Johnson&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=9PpPtkGOlVs:BqMdQiAyLB8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=9PpPtkGOlVs:BqMdQiAyLB8:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=9PpPtkGOlVs:BqMdQiAyLB8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=9PpPtkGOlVs:BqMdQiAyLB8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/9PpPtkGOlVs" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7197</feedburner:origLink></item><item><title>TECcare™ antimicrobial technology completes viral</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/Ft5YeK8Gze8/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;TECcare™ antimicrobial technology completes viral &lt;/strong&gt;&lt;br /&gt;Talley Environmental Care Ltd announces the completion of viral testing to As...&lt;br /&gt;Talley Environmental Care Ltd&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Ft5YeK8Gze8:PKVQ8pQqDXM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Ft5YeK8Gze8:PKVQ8pQqDXM:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Ft5YeK8Gze8:PKVQ8pQqDXM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=Ft5YeK8Gze8:PKVQ8pQqDXM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/Ft5YeK8Gze8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7196</feedburner:origLink></item><item><title>Notice Concerning the Determination of the Items of</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/d1DGck0GqwI/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Notice Concerning the Determination of the Items of&lt;/strong&gt;&lt;br /&gt;Osaka, Japan, July 13, 2009 - Takeda Pharmaceutical Company Limited (&amp;amp;ld...&lt;br /&gt;TAKEDA&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=d1DGck0GqwI:UcVQs3aTGlc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=d1DGck0GqwI:UcVQs3aTGlc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=d1DGck0GqwI:UcVQs3aTGlc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=d1DGck0GqwI:UcVQs3aTGlc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/d1DGck0GqwI" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7195</feedburner:origLink></item><item><title>FDA Approves Plan B® One-Step, a New One-Pill Emergency Contraceptive</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/WfS4cTalI0Q/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;FDA Approves Plan B® One-Step, a New One-Pill Emergency Contraceptive&lt;/strong&gt;&lt;br /&gt;Jerusalem, Israel, July 13, 2009 - Teva Pharmaceutical Ind...&lt;br /&gt;Teva Pharmaceuticals&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=WfS4cTalI0Q:lI73vlbtcfg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=WfS4cTalI0Q:lI73vlbtcfg:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=WfS4cTalI0Q:lI73vlbtcfg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=WfS4cTalI0Q:lI73vlbtcfg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/WfS4cTalI0Q" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7194</feedburner:origLink></item><item><title>Eisai Signs License Agreement in Japan for MENILET®, an Oral Osmotic Diuretic and Meniere’s Disease-Improving Agent</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/DHpkMm00Msk/pressrel.asp</link><pubDate>Mon, 13 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Eisai Signs License Agreement in Japan for MENILET®, an Oral Osmotic Diuretic and Meniere’s Disease-Improving Agent&lt;/strong&gt;&lt;br /&gt;Eisai Co., L...&lt;br /&gt;Eisai Co., Ltd&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=DHpkMm00Msk:24w0eVNFuE4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=DHpkMm00Msk:24w0eVNFuE4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=DHpkMm00Msk:24w0eVNFuE4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=DHpkMm00Msk:24w0eVNFuE4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/DHpkMm00Msk" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7193</feedburner:origLink></item><item><title>Ark launches Kerraglove® woundcare device for burns on the hand</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/eG6N0LJH9lo/pressrel.asp</link><pubDate>Sun, 12 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Ark launches Kerraglove® woundcare device for burns on the hand&lt;/strong&gt;&lt;br /&gt;London, UK, 13 July 2009 - Ark Therapeutics Group plc (AKT:LSE) ...&lt;br /&gt;Ark Therapeutics Group plc&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=eG6N0LJH9lo:DsEXkvjwClc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=eG6N0LJH9lo:DsEXkvjwClc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=eG6N0LJH9lo:DsEXkvjwClc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=eG6N0LJH9lo:DsEXkvjwClc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/eG6N0LJH9lo" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7188</feedburner:origLink></item><item><title>Johnson &amp; Johnson Completes Acquisition of Cougar Biotechnology</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/8zhIpluLucc/pressrel.asp</link><pubDate>Sun, 12 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Johnson &amp;amp; Johnson Completes Acquisition of Cougar Biotechnology&lt;/strong&gt;&lt;br /&gt;Late-Stage, First-in-Class Prostate Cancer Treatment Strengt...&lt;br /&gt;Johnson &amp;amp; Johnson&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=8zhIpluLucc:YY0LIxLcgz8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=8zhIpluLucc:YY0LIxLcgz8:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=8zhIpluLucc:YY0LIxLcgz8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=8zhIpluLucc:YY0LIxLcgz8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/8zhIpluLucc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7187</feedburner:origLink></item><item><title>Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/RA-t3FkPg8c/pressrel.asp</link><pubDate>Sun, 12 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)&lt;/strong&gt;&lt;br /&gt;Effient(TM) Reduces Thrombotic Cardiovascular Events in Patie...&lt;br /&gt;Lilly&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=RA-t3FkPg8c:ufuyyNi5WeM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=RA-t3FkPg8c:ufuyyNi5WeM:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=RA-t3FkPg8c:ufuyyNi5WeM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=RA-t3FkPg8c:ufuyyNi5WeM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/RA-t3FkPg8c" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7186</feedburner:origLink></item><item><title>Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/qs2R21Q9Br8/pressrel.asp</link><pubDate>Sun, 12 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation&lt;/strong&gt;&lt;b...&lt;br /&gt;Forest Laboratories&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=qs2R21Q9Br8:p4hHgy5ogjs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=qs2R21Q9Br8:p4hHgy5ogjs:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=qs2R21Q9Br8:p4hHgy5ogjs:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=qs2R21Q9Br8:p4hHgy5ogjs:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/qs2R21Q9Br8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7185</feedburner:origLink></item><item><title>Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/QZzOiT-YkRE/pressrel.asp</link><pubDate>Sun, 12 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)&lt;/strong&gt;&lt;br /&gt;MORRISTOWN, N.J., July 10 /PRNewswire-FirstCal...&lt;br /&gt;Watson Pharmaceuticals&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=QZzOiT-YkRE:gsVPujxTjXI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=QZzOiT-YkRE:gsVPujxTjXI:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=QZzOiT-YkRE:gsVPujxTjXI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=QZzOiT-YkRE:gsVPujxTjXI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/QZzOiT-YkRE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7184</feedburner:origLink></item><item><title>Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal® Vet, a New Chemotherapeutic Agent for Dogs</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/HtHj7aGL_24/pressrel.asp</link><pubDate>Sun, 12 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal® Vet, a New Chemotherapeutic Agent for Dogs&lt;/strong&gt;&lt;br ...&lt;br /&gt;Abbott&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=HtHj7aGL_24:ACVLJZUwmJE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=HtHj7aGL_24:ACVLJZUwmJE:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=HtHj7aGL_24:ACVLJZUwmJE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=HtHj7aGL_24:ACVLJZUwmJE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/HtHj7aGL_24" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7183</feedburner:origLink></item><item><title>Chiltern Announces Financial Results for Year End 31 March 2009</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/ako_67tUyO8/pressrel.asp</link><pubDate>Thu, 09 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Chiltern Announces Financial Results for Year End 31 March 2009&lt;/strong&gt;&lt;br /&gt;CHILTERN ANNOUNCES ITS FINANCIAL RESULTS FOR THE YEAR ENDED 31 M...&lt;br /&gt;Chiltern&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ako_67tUyO8:2YLBUdt02X4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ako_67tUyO8:2YLBUdt02X4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ako_67tUyO8:2YLBUdt02X4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=ako_67tUyO8:2YLBUdt02X4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/ako_67tUyO8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7175</feedburner:origLink></item><item><title>REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/i5ZKdEDRT4g/pressrel.asp</link><pubDate>Thu, 09 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients&lt;/strong&gt;&lt;br /&gt;KENILWORTH, N.J., July 9 /PRNewswire-FirstCal...&lt;br /&gt;Schering-Plough Corporation&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=i5ZKdEDRT4g:mlY0s3VxJrY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=i5ZKdEDRT4g:mlY0s3VxJrY:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=i5ZKdEDRT4g:mlY0s3VxJrY:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=i5ZKdEDRT4g:mlY0s3VxJrY:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/i5ZKdEDRT4g" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7173</feedburner:origLink></item><item><title>Dr Jeffrey Leiden appointed to Vertex Board</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/T7zw1R_91Q0/pressrel.asp</link><pubDate>Thu, 09 Jul 2009 18:00:00 PDT</pubDate><description>&lt;strong&gt;Dr Jeffrey Leiden appointed to Vertex Board&lt;/strong&gt;&lt;br /&gt;08 Jul 2009 - Basingstoke, UK and Philadelphia, US &amp;amp;ndash; Shire announces that ...&lt;br /&gt;Shire&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=T7zw1R_91Q0:lfMpe5KEK6I:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=T7zw1R_91Q0:lfMpe5KEK6I:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=T7zw1R_91Q0:lfMpe5KEK6I:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=T7zw1R_91Q0:lfMpe5KEK6I:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/T7zw1R_91Q0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7172</feedburner:origLink></item></channel></rss>
